NGM Biopharmaceuticals, Inc., a privately-held biopharmaceutical company, named Jeff Jonker president and David Woodhouse, Ph.D., as chief financial officer. Prior to joining NGM, Mr. Jonker was the senior vice president, corporate and business development at Theravance Biopharma and Theravance, Inc. He previously served as the chief business officer of Satori Pharmaceuticals and the vice president of business development and corporate strategy for Gloucester Pharmaceuticals, prior to its acq...